Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin

Area of Science:

• Cardiovascular Surgery
• Anesthesiology
• Pharmacology

Background:

• Pre-operative aspirin is commonly used for cardiovascular protection.
• Aspirin's antiplatelet effects can increase perioperative bleeding.
• Limited data exist on managing aspirin-induced bleeding in cardiac surgery.

Purpose of the Study:

• To evaluate the impact of pre-operative aspirin on blood loss and transfusion in coronary artery bypass grafting (CABG).
• To assess the efficacy of aprotinin and desmopressin in mitigating aspirin-related bleeding complications during CABG.

Main Methods:

• Conducted a Medline search to identify relevant studies.
• Performed a meta-analysis to synthesize data on pre-operative aspirin use and bleeding outcomes in CABG patients.
• Analyzed the effectiveness of aprotinin and desmopressin in counteracting increased bleeding.

Main Results:

• Pre-operative aspirin administration is associated with significantly increased blood loss following CABG.
• Patients on pre-operative aspirin required more blood transfusions.
• Both aprotinin and desmopressin demonstrated effectiveness in reducing bleeding and transfusion needs in this context.

Conclusions:

• Pre-operative aspirin significantly elevates bleeding risks and transfusion requirements in patients undergoing CABG.
• Aprotinin and desmopressin are effective interventions to manage aspirin-induced bleeding in CABG.
• Further research is needed on the bleeding effects of these agents in other surgical procedures.